The Patient Adherence Paradox

Published on 02/07/2019
The Patient Adherence Paradox

What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you...

In search of an answer to the $637 billion question, we explore the issues surrounding the frankly frighteningly low levels of medications adherence.

Why do patients stop taking drugs prescribed to help them? Side effects might be the obvious first thought, but the reality is that the reasons for nonadherence are complex, many, and varied.

Are expensive patient support programmes the only answer? We would argue that they aren’t, and that a commitment to understanding the behavioural roots of nonadherence may pay dividends in the longer term.

Click here to view IGNIFI's full article on the subject:

Our Valued Sponsors & Partners